An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
NCT05914766 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2025-05-18
Summary
The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.
Conditions
- Rectal Cancer
- Self Efficacy
Interventions
- BEHAVIORAL
-
PATHWAYS
The PATHWAYS intervention is a psychoeducational intervention comprised of four behavioral coaching sessions and a patient education guidebook.
- OTHER
-
Enhanced usual care
The enhanced usual care condition consists of an information resource guide.
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Kelsey Lau-Min, MD, MSCE · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-21
- Primary Completion
- 2028-05-21
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer
NCT05148767 ·Status: RECRUITING ·Phase: PHASE4
-
Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders
NCT03941366 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
NCT04749108 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Exercise for Adults Diagnosed With Rectal Cancer
NCT03049124 ·Status: WITHDRAWN ·Phase: NA
-
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
NCT06894797 ·Status: RECRUITING ·Phase: NA
-
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
NCT01437514 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer
NCT00939666 ·Status: COMPLETED ·Phase: NA
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
NCT05607186 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
NCT00960427 ·Status: WITHDRAWN ·Phase: PHASE1
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
NCT04215731 ·Status: RECRUITING ·Phase: PHASE3
-
Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
NCT06417476 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
NCT02107105 ·Status: RECRUITING
-
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
NCT05640726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer
NCT05622357 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer
NCT01613469 ·Status: TERMINATED ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT06304987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
NCT05984576 ·Status: RECRUITING
-
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
NCT00541112 ·Status: TERMINATED ·Phase: PHASE2
-
Planned Non-operative Management for Rectal Cancer
NCT05241574 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2